WilliamRMaconMD

Pathology • Rochester, MN

Hematopathology, Anatomic Pathology, Clinical Pathology

Professor, Laboratory Medicine & Pathology, Mayo Medical School

Join to view full profile

Dr. Macon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Macon's full profile

Already have an account?

Office
200 1st St Sw
Rochester, MN 55905
Phone+1 507-284-2511

Education & Training

Vanderbilt University Medical CenterResidency, Pathology-Anatomic and Clinical, 1984 - 1991
Medical University of South CarolinaClass of 1984

Certifications & Licensure

TN State Medical License 1989 - 2025
MN State Medical License 1999 - 2023
American Board of Pathology Anatomic Pathology
American Board of Pathology Clinical Pathology
American Board of Pathology Hematology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Publications & Presentations

PubMed

1 citations
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.
Sanjal H Desai, Levi Pederson, Betsy LaPlant, Raphael Mwangi, Matthew Maurer
Blood Cancer Journal. 2022-05-03
Histiocyte-rich pseudotumor - a post-chemotherapy radiologic dilemma.
Aishwarya Ravindran, William R Macon, Karen L Rech
Journal of Hematopathology. 2022-03-01
3 citations
Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from fol...
Sanjal Desai, Betsy LaPlant, William R. Macon, Rebecca L. King, Yucai Wang
Blood Cancer Journal. 2021-09-25

Abstracts/Posters

Potential Factors That Impact Lenalidomide/R-CHOP Efficacy in Previously Untreated Diffuse Large B-Cell Lymphoma in the ROBUST and ECOG-ACRIN 1412 Studies
William R. Macon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Genomic Analysis of R2CHOP-Treated DLBCL Reveals a High-Risk Population Driven By Inflammatory Pathways
William R. Macon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

An Analysis of a Multidisciplinary Lymphoma Virtual Tumor Board with Regional and International Participation
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

SOLAHP: A Fledgling Organization Rapidly Taking FlightAugust 31st, 2019
Keeping Tabs on the Mabs: A Hematopathologist’s DilemmaFebruary 22nd, 2019

Grant Support

Core--BiospecimensNational Cancer Institute2002